PathGroup Launches New SmartGenomics™ Cancer-Specific Testing

Provides Newly Diagnosed Patients Genomic Baseline BRENTWOOD, TENN. – (June 18, 2015) – PathGroup, one of the largest private providers of pathology services in the United States, announced today the launch of new cancer-specific SmartGenomics™ testing, expanding their genomic profiling menu for community-based oncologists. The addition of five diagnostic panels targeting cancers of lung, colon, […]

Read More

Latest advances on cancer research

Tennessee Oncology’s own Drs. Burris, Spigel, Bendell, and Hamilton discuss the direction that cancer research is taking at SCRI, on Fox & Friends.

Read More